HSP90AA1 and cancer: NVP-AUY922, a small molecule inhibitor for Hsp90N, is a resorcinol derivative based on the structure of 4,5-diarylisoxazole scaffold, and displayed favorable anti-cancer activity in vitro and in vivo (16).